P3 Health Partners (PIII) Gains from Investment Securities (2021 - 2026)

P3 Health Partners (PIII) has 5 years of Gains from Investment Securities data on file, last reported at -$5.1 million in Q4 2025.

• Quarterly Gains from Investment Securities rose 32.35% year-over-year to -$5.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$7.8 million (up 64.5% YoY) and the FY2025 annual result came in at -$7.8 million, up 64.5% from the prior year.
• Gains from Investment Securities slipped to -$5.1 million in Q4 2025, from $2.5 million in the prior quarter.
• In the past five years, Gains from Investment Securities ranged from a high of $9.9 million in Q2 2021 to a low of -$11.8 million in Q2 2022.
• A 5-year average of -$1.8 million and a median of -$760000.0 in 2023 frame the typical range for Gains from Investment Securities.
• Annual changes were most pronounced in 2022 — Gains from Investment Securities jumped 210.56% — and 2025, when it sank 1437.96%.
• Tracing PIII's Gains from Investment Securities over 5 years: stood at -$5.5 million in 2021, then surged by 101.98% to $109000.0 in 2022, then slumped by 797.25% to -$760000.0 in 2023, then sank by 885.26% to -$7.5 million in 2024, then jumped by 32.35% to -$5.1 million in 2025.
• The last three Gains from Investment Securities figures came in at -$5.1 million (Q4 2025), $2.5 million (Q3 2025), and -$2.0 million (Q2 2025), per Business Quant data.